O'Brien M - Search Results

1

Active symptom control with or without chemotherapy in the treatment of patients with malignant pleural mesothelioma (MS01): a multicentre randomised trial.

Muers MF, Stephens RJ, Fisher P, Darlison L, Higgs CM, Lowry E, Nicholson AG, O'Brien M, Peake M, Rudd R, Snee M, Steele J, Girling DJ, Nankivell M, Pugh C, Parmar MK; MS01 Trial Management Group. Muers MF, et al. Lancet. 2008 May 17;371(9625):1685-94. doi: 10.1016/S0140-6736(08)60727-8. Lancet. 2008. PMID: 18486741 Free PMC article. Clinical Trial.

2

The role of metoclopramide in acute and delayed chemotherapy induced emesis: a randomised double blind trial.

O'Brien ME, Cullen MH, Woodroffe C, Kelly K, Burman C, Palmer K, Stuart NS, Blackledge GR, Sharpe J. O'Brien ME, et al. Br J Cancer. 1989 Nov;60(5):759-63. doi: 10.1038/bjc.1989.354. Br J Cancer. 1989. PMID: 2679853 Free PMC article. Clinical Trial.

3

Therapeutic progress--review XXVIII. Are we making progress in the management of cytotoxic drug-induced nausea and vomiting?

O'Brien ME, Cullen MH. O'Brien ME, et al. J Clin Pharm Ther. 1988 Feb;13(1):19-31. doi: 10.1111/j.1365-2710.1988.tb00503.x. J Clin Pharm Ther. 1988. PMID: 3283155 Review. No abstract available.

4

Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumours.

Ellis PA, Norman A, Hill A, O'Brien ME, Nicolson M, Hickish T, Cunningham D. Ellis PA, et al. Eur J Cancer. 1995 Sep;31A(10):1594-8. doi: 10.1016/0959-8049(95)00323-b. Eur J Cancer. 1995. PMID: 7488407 Clinical Trial.

5

Phase I study of mitozantrone, methotrexate and mitomycin with granulocyte colony-stimulating factor (filgrastim) in patients with advanced breast cancer.

O'Brien ME, Nicolson M, Montes A, Tidy A, Ashley S, Powles TJ. O'Brien ME, et al. Br J Cancer. 1994 Nov;70(5):980-3. doi: 10.1038/bjc.1994.433. Br J Cancer. 1994. PMID: 7524607 Free PMC article. Clinical Trial.

6

Inefficacy of calcipotriol in skin metastases from breast cancer.

O'Brien ME, Talbot D, Maclennan K, Smith IE. O'Brien ME, et al. Lancet. 1993 Oct 16;342(8877):994. doi: 10.1016/0140-6736(93)92042-r. Lancet. 1993. PMID: 8105245 No abstract available.

7

Phase II study of continuous infusion fluorouracil with epirubicin and cisplatin in patients with metastatic and locally advanced breast cancer: an active new regimen.

Jones AL, Smith IE, O'Brien ME, Talbot D, Walsh G, Ramage F, Robertshaw H, Ashley S. Jones AL, et al. J Clin Oncol. 1994 Jun;12(6):1259-65. doi: 10.1200/JCO.1994.12.6.1259. J Clin Oncol. 1994. PMID: 8201387 Clinical Trial.

8

Carboplatin in the treatment of advanced breast cancer: a phase II study using a pharmacokinetically guided dose schedule.

O'Brien ME, Talbot DC, Smith IE. O'Brien ME, et al. J Clin Oncol. 1993 Nov;11(11):2112-7. doi: 10.1200/JCO.1993.11.11.2112. J Clin Oncol. 1993. PMID: 8229125 Clinical Trial.

9

Primary medical (neo-adjuvant) chemotherapy for operable breast cancer.

Smith IE, Jones AL, O'Brien ME, McKinna JA, Sacks N, Baum M. Smith IE, et al. Eur J Cancer. 1993;29A(12):1796-9. doi: 10.1016/0959-8049(93)90133-z. Eur J Cancer. 1993. PMID: 8398318 Clinical Trial.

10

Phase II study of continuous infusional 5-fluorouracil with epirubicin and carboplatin (instead of cisplatin) in patients with metastatic/locally advanced breast cancer (infusional ECarboF): a very active and well-tolerated outpatient regimen.

Bonnefoi H, Smith IE, O'Brien ME, Seymour MT, Powles TJ, Allum WH, Ebbs S, Baum M. Bonnefoi H, et al. Br J Cancer. 1996 Feb;73(3):391-6. doi: 10.1038/bjc.1996.67. Br J Cancer. 1996. PMID: 8562348 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,321 results

Search Page